Penile Length Maintenance Post-Prostatectomy

Overview

About this study

The objective of the current study is to evaluate the efficacy of a novel, class I (ie. lowest risk, clinical studies not required) medical penile traction device in preventing loss of penile length in men undergoing robotic-assisted prostatectomy.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Undergoing robotic prostatectomy
Seen in the post-prostatectomy rehab clinic

Exclusion Criteria:

Urethral complications from prostatectomy at the time of baseline visit (Complications include contrast extravasation, anastomotic dehiscence of vesicourethral anastomosis, need for re-doing of vasicourethral anastomosis intra-operatively)

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Landon Trost, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Landon Trost, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials